| |
Disclaimer |
|
|
| |
KERAMED INC. maintains its website to provide investors, partners, customers and other external parties with information regarding the company's strategic, business, technical and operational matters. However, since corneal research evolves quickly, KERAMED INC. cannot warrant that this information at any point in time is current, complete or without inaccuracies. KERAMED INC. also disclaims any forward-looking statements contained in this website. Examples include statements regarding the potential benefit offered to patients with cornea blindness. Actual results may differ materially from those projected in such forward-looking statements due to various factors out of KERAMED INC.'s control. Other forward-looking statements include statements regarding business progress, product development, intellectual property, etc. KERAMED INC. is an emerging business and therefore subject to risks and uncertainties. We cannot be responsible for any financial or other damages that may occur through any use of the information found on this website. |
|
 |
News |
|
| We have received our license to sell the EndoInjector in Canada. Orders will be taken at ASCRS or by calling our office at 408-752-0850 |
|
KeraMed Inc. receives a grant under the U.S. Qualified Therapeutic Discovery Project Program
Drs. John Kanellopoulos and Jose Vargas successfully perform first micro-incision artificial cornea implantations with KeraKlear. |
|
| |
| |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
